Despite recent findings that CAF-derived HAPLN1 promotes tumor invasion in gastric cancer (24), our data reveal that HAPLN1 is predominantly expressed in NAT tissues, with expression levels sharply decreasing in tumor tissues. The gene discussed is HAPLN1; the disease is neoplasm.